Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics

Support Care Cancer. 1998 May;6(3):244-7. doi: 10.1007/s005200050161.

Abstract

Cancer chemotherapy is known to lead to nausea and vomiting in a large proportion of cases. If emesis is severe it can lead in its turn to anticipatory nausea and vomiting (ANV), which cannot be controlled by antiemetic medication. The etiology of ANV and various methods that have been used to counteract the condition are discussed.

Publication types

  • Consensus Development Conference
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Antiemetics / adverse effects
  • Antiemetics / therapeutic use*
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Behavior Therapy
  • Humans
  • Nausea / chemically induced
  • Nausea / drug therapy*
  • Neoplasms / drug therapy*
  • Palliative Care*
  • Receptors, Serotonin / drug effects*
  • Receptors, Serotonin, 5-HT3
  • Serotonin Antagonists / adverse effects
  • Serotonin Antagonists / therapeutic use*
  • Treatment Outcome
  • Vomiting, Anticipatory / chemically induced
  • Vomiting, Anticipatory / drug therapy*

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Receptors, Serotonin
  • Receptors, Serotonin, 5-HT3
  • Serotonin Antagonists